logo-loader
LON:HVO

hVIVO PLC

Receive alerts
Market:
LON
Market Cap:
£16.21 m
Price
£0.20
Change
-2.50%
52 weeks high
74.40
52 weeks low
18.00

In brief

Established in 1989 as a spin out from Queen Mary University, London, hVIVO is a trusted partner and industry-leading clinical development services business pioneering human disease models based upon viral challenge. Using human challenge studies to establish early proof-of-concept, hVIVO’s clinical trial platform can accelerate drug and vaccine development in respiratory and infectious disease.

hVIVO conducts studies and provides services for customers, both pharmaceutical and biotech companies, utilising a range of different client trial and laboratory methodologies across differing viral challenges. Experience and know-how from over 50 challenge studies is applied to ensure effective study design and excellent service delivery for customers.